№ lp_1_24256
File format: docx
Character count: 4080
File size: 66 KB
This document provides a tapering schedule for reducing diazepam dosage in patients undergoing benzodiazepine withdrawal, as part of a medical guideline for clinicians.
Year:
2023
Region / city:
UK
Topic:
Tapering regimen for benzodiazepine withdrawal
Document type:
Medical guideline
Organization / institution:
NHS Wales
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
N/A
Topic:
Veterinary care
Document type:
Instruction manual
Organization:
N/A
Author:
N/A
Target audience:
Pet owners
Period of validity:
N/A
Approval date:
N/A
Amendment date:
N/A
Note:
Year
Year:
2021
Language:
English
Medical field:
Pain management
Therapeutic class:
Gabapentinoids
Medications covered:
Gabapentin; Pregabalin
Indications discussed:
Neuropathic pain
Patient population:
Adults with persistent pain
Document type:
Clinical guidance
Related guidance:
Analgesic Tapering Guidelines for adult patients with persistent pain taking strong opioids and/or gabapentinoids
Regulatory references:
NICE; MHRA
Dosage information:
Included
Tapering schedules:
Included
Risk considerations:
Adverse effects; withdrawal effects; opioid co-prescribing risks
Geographic context:
United Kingdom
Evidence sources:
Cochrane Reviews; NICE guidance; Summary of Product Characteristics
Year:
not specified
Country:
United Kingdom
Medication:
Zopiclone
Therapeutic class:
Hypnotic
Indication:
Insomnia
Licensed use duration:
Up to 4 weeks
Adult licensed dose:
7.5 mg at bedtime
Elderly licensed dose:
3.75–7.5 mg at bedtime
Off-licence use:
Yes
Primary topic:
Dose reduction and withdrawal
Withdrawal risks:
Physical and psychological withdrawal symptoms
Target population:
Adult patients using zopiclone long term
Recommended tapering pace:
No faster than one change per week
Dose forms:
3.75 mg tablets, 7.5 mg tablets
Reference bodies:
All Wales Medicines Strategy Group; NICE
Document components:
Clinical guidance; tapering schedule; patient reduction record
Note:
Year
Year:
2024
Region / City:
Middletown
Theme:
Condominium Regulations
Document Type:
Governing Rules
Organization / Institution:
Council of Co-owners of Dorsey Station Condominiums
Author:
Board of Administration of the Council of Co-owners
Target Audience:
Dorsey Station Condominium Property Owners
Effective Date:
September 24, 2024
Amendment Date:
September 24, 2024
Approval Date:
September 24, 2024
Year:
2023
Region / City:
North Somerset
Theme:
Health Care Services, Procurement
Document Type:
Procurement Regulation
Organization / Institution:
North Somerset Council
Author:
North Somerset Council
Target Audience:
Providers of health care services
Effective Period:
From 01/04/2026 to 31/03/2029
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Year:
not specified
Country:
United Kingdom
Medication:
Zopiclone
Therapeutic class:
Hypnotic
Indication:
Insomnia
Licensed use duration:
Up to 4 weeks
Adult licensed dose:
7.5 mg at bedtime
Elderly licensed dose:
3.75–7.5 mg at bedtime
Off-licence use:
Yes
Primary topic:
Dose reduction and withdrawal
Withdrawal risks:
Physical and psychological withdrawal symptoms
Target population:
Adult patients using zopiclone long term
Recommended tapering pace:
No faster than one change per week
Dose forms:
3.75 mg tablets, 7.5 mg tablets
Reference bodies:
All Wales Medicines Strategy Group; NICE
Document components:
Clinical guidance; tapering schedule; patient reduction record
Year:
2021
Region / City:
United Kingdom
Subject:
Intellectual Property, Parallel Trade, Exhaustion Regime
Document Type:
Consultation Response Form
Organization:
Intellectual Property Office (IPO)
Author:
UK Government
Target Audience:
Businesses, Organizations, and Individuals involved in intellectual property
Period of validity:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Date:
[Insert DD Month YYYY]
Jurisdiction:
Australia
Subject:
Tax File Number withholding obligations for closely held trusts
Document Type:
Advisory letter
Addressee:
[Insert Client Name]
Author:
[Insert name of Partner]
Relevant Authority:
Australian Taxation Office
Applicable Tax Year:
Year ended 30 June 2024
Withholding Rate:
47% (highest marginal tax rate plus Medicare levy)
Compliance Obligations:
PAYG withholding registration, annual TFN withholding report, annual payment summary, remittance of withheld amounts
Reporting Deadlines:
30 September, 14 October, 28 October
Penalties:
Administrative penalties for failure to withhold, remit or report
Year:
2023
Region / City:
England
Subject:
Health Care Services
Document Type:
Tender Invitation
Organization:
NHS England
Author:
NHS England
Target Audience:
Tenderers interested in providing mental health services
Effective Period:
2023-2025
Approval Date:
Not specified
Modification Date:
Not specified
Contract Type:
Service contract for National Staff Mental Health Support Service
Year:
2014
Region / City:
Ireland
Topic:
Legal Reforms, Court Structure
Document Type:
Legal Article
Author:
Eoin Martin B.L.
Target Audience:
Legal professionals, scholars, policymakers
Period of Application:
Ongoing since 28 October 2014
Approval Date:
28 October 2014
Date of Amendments:
N/A
Year:
2022
Region / City:
London
Subject:
SIRE 2.0 Inspection Program
Document Type:
Report
Organization / Institution:
Oil Companies International Marine Forum (OCIMF)
Author:
Sam Megwa, Programmes Director, OCIMF
Target Audience:
Vessel owners, operators, managers, crew, inspectors, recipients of inspection reports
Period of Effect:
Q2 2022
Approval Date:
18 January 2022
Date of Changes:
-
Year:
2022
Region / city:
Geneva
Topic:
Radio astronomy, broadband detectors, cosmic microwave background, millimetre-wave regime
Document type:
Report
Organization:
International Telecommunication Union (ITU)
Author:
ITU Study Group
Target audience:
Radiocommunication professionals, astronomers, researchers in cosmology
Effective period:
Not specified
Approval date:
2022
Amendment date:
Not specified
Context:
This document outlines the technical and operational characteristics of broadband, background-limited detectors used in radio astronomy, specifically for measuring the cosmic microwave background (CMB) in the millimetre-wave regime.
Type of Document:
Academic research article
Country:
Nigeria
Study Period:
1986–2020
Subject:
Value Added Tax (VAT), Poverty Reduction, Economic Growth
Methodology:
Simple Linear Regression Analysis
Authors:
Oladele O. Aluko; Ibrahim Musa; Yahaya Ismail
Affiliation:
Department of Economics, University of Abuja
Institution:
University of Abuja
VAT Rate Referenced:
7.5% (effective 1 February 2020; previously 5%)
Key Institutions Mentioned:
Federal Inland Revenue Service (FIRS); Central Bank of Nigeria
Keywords:
Value Added Tax (VAT); Poverty Reduction; Economic Growth; Tax Administration; Fiscal Policy
Year:
2026
Region / City:
Aalborg
Topic:
Digital Authoritarianism, Journalism, Political Regimes
Document Type:
Master Thesis
Organization / Institution:
Aalborg University
Author:
Martina Hrgović
Target Audience:
Scholars, Researchers, Journalists
Period of Validity:
January 6, 2026
Date of Approval:
January 6, 2026
Date of Changes:
None
Year:
2024
Note:
Region / City
Subject:
Missile Technology Control
Document Type:
Annex
Organization:
Missile Technology Control Regime
Approval Date:
14th March 2024